safinamide has been researched along with 8-(3-chlorostyryl)caffeine in 3 studies
| Studies (safinamide) | Trials (safinamide) | Recent Studies (post-2010) (safinamide) | Studies (8-(3-chlorostyryl)caffeine) | Trials (8-(3-chlorostyryl)caffeine) | Recent Studies (post-2010) (8-(3-chlorostyryl)caffeine) |
|---|---|---|---|---|---|
| 199 | 29 | 159 | 101 | 0 | 22 |
| Protein | Taxonomy | safinamide (IC50) | 8-(3-chlorostyryl)caffeine (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.0385 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0385 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.1603 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gütschow, M; Heer, J; Hinz, S; Küppers, P; Müller, CE; Schlenk, M; Stössel, A | 1 |
| Akkari, R; Borrmann, T; Brunschweiger, A; Drabczyńska, A; Hockemeyer, J; Kieć-Kononowicz, K; Koch, P; Köse, M; Küppers, P; Müller, CE; Radjainia, H; Schlenk, M | 1 |
| Almos, T; Edmondson, DE; Massari, ME; Rojas, RJ; Scott, R | 1 |
3 other study(ies) available for safinamide and 8-(3-chlorostyryl)caffeine
| Article | Year |
|---|---|
Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones.
Topics: Adenosine A2 Receptor Antagonists; Animals; Benzothiadiazines; Brain; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Humans; In Vitro Techniques; Isoenzymes; Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenylbutyrates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Stereoisomerism; Structure-Activity Relationship; Thiazines | 2013 |
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; CHO Cells; Cricetulus; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Purinergic P1 Receptor Antagonists; Purines; Xanthines | 2013 |
Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques.
Topics: Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Small Molecule Libraries; Thermodynamics | 2015 |